Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Samsung Bioepis, Biogen Announce FDA Filing Acceptance of Lucentis Biosimilar

americanpharmaceuticalreviewDecember 04, 2020

Tag: Samsung Bioepis , Biogen , SB11 , Lucentis , ranibizumab

PharmaSources Customer Service